Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
INTRODUCTION:The first-line combination therapy for HIV-associated cryptococcal meningitis (CM), a condition of high mortality particularly in the first two weeks of treatment, consists of amphotericin B plus flucytosine (5-FC). Given that 5-FC remains unavailable in many countries, the knowledge of...
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Public Library of Science (PLoS)
2017-01-01
|
| Schriftenreihe: | PLoS ONE |
| Online Zugang: | http://europepmc.org/articles/PMC5371305?pdf=render |